New Research on Pseudomonas putida from Kermanshah University of Medical Sciences Summarized (Novel Pseudomonas putida-derived nanoliposomes enhance the inhibition of MCF-7 breast cancer cells by superb intracellular uptake of doxorubicin).

Předmět:	GRAM-negative aerobic bacteria AEROBIC bacteria GRAM-negative bacteria GAMMAPROTEOBACTERIA PSEUDOMONAS putida
Zdroj:	Women's Health Weekly; 10/15/2024, p757-757, 1p
Abstrakt:	A recent study conducted by researchers at Kermanshah University of Medical Sciences in Iran has explored the use of nanoliposomes derived from the bacterium Pseudomonas putida (PP) for delivering the anti-cancer drug doxorubicin (Dox) to MCF-7 breast cancer cells. The researchers found that the nanoliposomes exhibited favorable physicochemical properties and were able to effectively deliver Dox to the cancer cells, resulting in cytotoxicity and increased apoptosis. The study suggests that PP phospholipids have the potential to be used as a promising drug delivery system for the treatment of various types of cancer. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu